These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 30496270)

  • 21. In vitro activity of tedizolid against the Mycobacterium abscessus complex.
    Compain F; Soroka D; Heym B; Gaillard JL; Herrmann JL; Dorchène D; Arthur M; Dubée V
    Diagn Microbiol Infect Dis; 2018 Mar; 90(3):186-189. PubMed ID: 29217419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact on Macrolide Resistance of Genetic Diversity of Mycobacterium abscessus Species.
    Jong BE; Wu TS; Chen NY; Yang CH; Shu CC; Wang LS; Wu TL; Lu JJ; Chiu CH; Lai HC; Chung WH
    Microbiol Spectr; 2022 Dec; 10(6):e0274922. PubMed ID: 36416559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Standardized interpretation of antibiotic susceptibility testing and resistance genotyping for Mycobacterium abscessus with regard to subspecies and erm41 sequevar.
    Mougari F; Amarsy R; Veziris N; Bastian S; Brossier F; Berçot B; Raskine L; Cambau E
    J Antimicrob Chemother; 2016 Aug; 71(8):2208-12. PubMed ID: 27147307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acquisition of clarithromycin resistance mutations in the 23S rRNA gene of Mycobacterium abscessus in the presence of inducible erm(41).
    Maurer FP; Rüegger V; Ritter C; Bloemberg GV; Böttger EC
    J Antimicrob Chemother; 2012 Nov; 67(11):2606-11. PubMed ID: 22833642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the GenoType NTM-DR assay performance for the identification and molecular detection of antibiotic resistance in Mycobacterium abscessus complex.
    Bouzinbi N; Marcy O; Bertolotti T; Chiron R; Bemer P; Pestel-Caron M; Peuchant O; Guet-Revillet H; Fangous MS; Héry-Arnaud G; Ouedraogo AS; Bañuls AL; Godreuil S
    PLoS One; 2020; 15(9):e0239146. PubMed ID: 32976521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug susceptibility patterns of Mycobacterium abscessus and Mycobacterium massiliense isolated from respiratory specimens.
    Cho EH; Huh HJ; Song DJ; Lee SH; Kim CK; Shin SY; Ki CS; Jhun BW; Moon SM; Kwon OJ; Koh WJ; Lee NY
    Diagn Microbiol Infect Dis; 2019 Feb; 93(2):107-111. PubMed ID: 30236529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm(41) and rrl sequencing.
    Bastian S; Veziris N; Roux AL; Brossier F; Gaillard JL; Jarlier V; Cambau E
    Antimicrob Agents Chemother; 2011 Feb; 55(2):775-81. PubMed ID: 21135185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predominance of clarithromycin-susceptible Mycobacterium massiliense subspecies: Characterization of the Mycobacterium abscessus complex at a tertiary acute care hospital.
    Chew KL; Cheng JWS; Hudaa Osman N; Lin RTP; Teo JWP
    J Med Microbiol; 2017 Oct; 66(10):1443-1447. PubMed ID: 28874233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulmonary Mycobacterium abscessus Subspecies abscessus Disease That Showed a Discrepancy Between the Genotype and Phenotype of Clarithromycin Resistance.
    Yamaba Y; Takakuwa O; Saito M; Kawae D; Yoshihara M; Mori Y; Kunii E; Ito Y; Yoshida S; Akita K
    Intern Med; 2019 Sep; 58(18):2675-2678. PubMed ID: 31178483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria.
    Mougari F; Loiseau J; Veziris N; Bernard C; Bercot B; Sougakoff W; Jarlier V; Raskine L; Cambau E;
    J Antimicrob Chemother; 2017 Jun; 72(6):1669-1677. PubMed ID: 28333340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minimum Inhibitory Concentrations before and after Antibacterial Treatment in Patients with Mycobacterium abscessus Pulmonary Disease.
    Fujiwara K; Uesugi F; Furuuchi K; Tanaka Y; Yoshiyama T; Saotome M; Ohta K; Mitarai S; Morimoto K
    Microbiol Spectr; 2021 Dec; 9(3):e0192821. PubMed ID: 34878300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid detection of mutations in erm(41) and rrl associated with clarithromycin resistance in Mycobacterium abscessus complex by denaturing gradient gel electrophoresis.
    Liu W; Li B; Chu H; Zhang Z; Luo L; Ma W; Yang S; Guo Q
    J Microbiol Methods; 2017 Dec; 143():87-93. PubMed ID: 29079298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discrepancies between the genotypes and phenotypes of clarithromycin-resistant
    Yoshida S; Tsuyuguchi K; Kobayashi T; Tomita M; Inoue Y; Hayashi S; Suzuki K
    Int J Tuberc Lung Dis; 2018 Apr; 22(4):413-418. PubMed ID: 29562989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between sequevar and antibiotic treatment outcome in patients with Mycobacterium abscessus complex infections in Japan.
    Yoshida S; Tsuyuguchi K; Kobayashi T; Tomita M; Inoue Y; Hayashi S; Suzuki K
    J Med Microbiol; 2018 Jan; 67(1):74-82. PubMed ID: 29227218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The analysis of species identification and susceptibility testing of Mycobacterium abscessus].
    Nie W; Duan H; Huang H; Lu Y; Chu N
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jul; 37(7):517-21. PubMed ID: 25262693
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Brown-Elliott BA; Wallace RJ
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30509936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular characterization of Mycobacterium abscessus subspecies isolated from patients attending an Italian Cystic Fibrosis Centre.
    Teri A; Sottotetti S; Arghittu M; Girelli D; Biffi A; D'Accico M; Daccò V; Gambazza S; Pizzamiglio G; Trovato A; Tortoli E; Colombo C; Cariani L
    New Microbiol; 2020 Jul; 43(3):127-132. PubMed ID: 32656572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Erm(41)-dependent inducible resistance to azithromycin and clarithromycin in clinical isolates of Mycobacterium abscessus.
    Maurer FP; Castelberg C; Quiblier C; Böttger EC; Somoskövi A
    J Antimicrob Chemother; 2014 Jun; 69(6):1559-63. PubMed ID: 24500188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differentiation between persistent infection/colonization and re-infection/re-colonization of Mycobacterium abscessus isolated from patients in Northeast Thailand.
    Kham-Ngam I; Chetchotisakd P; Ananta P; Chaimanee P; Reechaipichitkul W; Lulitanond V; Namwat W; Faksri K
    Infect Genet Evol; 2019 Mar; 68():35-42. PubMed ID: 30521865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of Mycobacterium abscessus Pulmonary Disease.
    Griffith DE; Daley CL
    Chest; 2022 Jan; 161(1):64-75. PubMed ID: 34314673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.